When will Beam Therapeutics submit a BLA for Risto-cel?

Kalshi Health › FDA & drugs Closes Apr 1, 2027 · $3.2K traded · $1.9K at stake · prices read 2 h ago

The odds

72%before April 2027

before April 202772%
before 202752%
before December33%▼ 1
before November7%

How the odds have moved

Not enough history yet.

Each outcome's chance over time on Kalshi. The dots along the bottom are headlines about its subject: point at one to read it.

Every outcome

Outcome	Chance	Day	Bid	Ask	Pays	Contracts
before April 2027	72%		68¢	76¢	$1.32	2.6K
before 2027	52%		50¢	53¢	$1.89	447
before December	33%	▼ 1	29¢	36¢	$2.78	2.2K
before November	7%		6¢	8¢	$12.50	2.8K
before October	2%				$50.00	9.5K
before September	1%				$100.00	7.5K

"Pays" is what a $1 stake returns if that outcome happens, at the price shown (before any fees). Bid and ask are the best prices to sell and buy "Yes".

The news: Beam Therapeutics, Risto-cel, Ristoglogene

Search ›

No recent headlines name this market's subject.

Related markets

All fda & drugs ›

Health › FDA & drugs

FDA decision: Anitocabtagene Autoleucel (anito-cel) by Gilead Sciences (in 2026)

89%chance▼ 4

Health › FDA & drugs

When will the FDA reclassify BPC-157 to Category 1?

29%Before 2027

Before 202729%▼ 10
Before November14%▲ 4

Health › FDA & drugs

Will the FDA approve any psychedelic substance for medical use this year? (Before 2027)

19%chance▼ 2

Health › FDA & drugs

Will the FDA approve retatrutide? (retatrutide (LY3437943))

Oct 14, 2027even chance by

Before Jan 1, 20274%
Before Jul 1, 202720%▲ 1
Before Jan 1, 202873%▲ 1

2 more

Before Jul 1, 202887%▼ 1
Before Jan 1, 202991%▼ 1

Health › FDA & drugs

Will the FDA approve cytisinicline for smoking cessation?

39%Before Jul 1, 2027

Before Jan 1, 202711%▲ 1
Before Jul 1, 202739%

Health › FDA & drugs

Will the FDA approve a cure for Type 1 diabetes before 2033?

39%chance▼ 2

Odds are traders' prices on Kalshi, Polymarket, ForecastEx and Crypto.com, not forecasts by 4Conservative. Prices read from the venues 4 min ago. Prices may be delayed. Money traded on Kalshi and ForecastEx is estimated from contracts. Not betting or investment advice.

About this market

VenueKalshi

Settles onFood and Drug Administration, Beam Therapeutics

Trading closesApr 1, 2027 10:00 AM ET

Traded$3.2K (24,982 contracts)

This week$3.2K

At stake$1.9K

Followed here sinceOct 19, 2026

The rules

If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Sep 1, 2026, then the market resolves to Yes.

The full rules are on the market's page at Kalshi.

Reading the odds

A prediction market trades contracts that pay $1 if something happens. Its price is the market's chance: a contract at 62¢ means traders give it 62%. Each number here is the midpoint between the best bid and offer, or the last trade when they are more than ten cents apart.

For a question with many answers (who wins, which range a number lands in), the chances are scaled to add up to 100%. A price ladder ("above 4.25%, above 4.50% ...") gives a whole distribution: its median is where traders see an even chance either way.

Kalshi is a U.S. exchange regulated by the CFTC; its money is counted in contracts, shown here as dollars at their price. Polymarket counts dollars. ForecastEx is Interactive Brokers' exchange, regulated by the CFTC; its contracts too are shown as dollars at their price. Crypto.com lists its markets on Crypto.com | Derivatives North America, a U.S. exchange regulated by the CFTC; it reports the dollars traded. Where more than one asks the same question, each is shown, never averaged.

Prefer betting odds? Switch to American (+150) or decimal (2.50) odds at the top of the page.

Prediction-market prices are what traders pay for each outcome on Kalshi, Polymarket, ForecastEx and Crypto.com, read as the market's implied chance. They are not forecasts by 4Conservative, can move fast and can be wrong; they are read every few minutes and may be delayed. Money traded on Kalshi and ForecastEx is estimated from contracts at their price. News comes from the 4Conservative index; prices of stocks, rates and coins from 4Conservative Finance. Nothing here is betting, financial or investment advice. Terms of use.